tiprankstipranks

New Portfolio - New Portfolio

Jason Moore

New Portfolio
Individual Investor
Ranked #107,907 out of 775,923 TipRanks' Investors
Success Rate
42%
44 out of 104
profitable transactions
Average Return
53.47%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▲ 10.74%
6-Month Return▲ 28.86%
12-Month Return-
YTD Return▲ 3.23%
Total Return▲ 3.23%

Best Trade

Opened at
Closed at-
Gain▲ 2433.21%

Bio

Performance

43.22%0-43.22%
▲ 11.46%
▲ 5.06%
▲ 2.86%
May 2024
▼ 2.25%
▲ 3.53%
▼ 4.22%
Jun 2024
▲ 25.71%
▲ 1.21%
▲ 10.90%
Jul 2024
▼ 4.22%
▲ 2.34%
▼ 6.15%
Aug 2024
▲ 7.82%
▲ 2.10%
▼ 1.00%
Sep 2024
▲ 5.38%
▼ 0.89%
▲ 3.08%
Oct 2024
▲ 43.22%
▲ 5.96%
▲ 18.48%
Nov 2024
▼ 0.45%
▼ 1.56%
▲ 1.57%
Dec 2024
TipRanks AverageS&P 500Investor Portfolio
▲ 11.46%▲ 5.06%▲ 2.86%
▼ 2.25%▲ 3.53%▼ 4.22%
▲ 25.71%▲ 1.21%▲ 10.90%
▼ 4.22%▲ 2.34%▼ 6.15%
▲ 7.82%▲ 2.10%▼ 1.00%
▲ 5.38%▼ 0.89%▲ 3.08%
▲ 43.22%▲ 5.96%▲ 18.48%
▼ 0.45%▼ 1.56%▲ 1.57%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Petiq
▲ 69.01%
2
Close
Oct 24, 2024
Terran Orbital Corp
▼ 70.78%
2
Close
Aug 21, 2024
Avidity Biosciences
0.99%
▲ 48.28%
1
Open
Mar 08, 2024
Opus Genetics
0.99%
▼ 50.85%
1
Open
Mar 08, 2024
NRX Pharmaceuticals
0.99%
▼ 75.55%
1
Open
Mar 08, 2024
Abeona Therapeutics
0.99%
▼ 28.48%
1
Open
Mar 08, 2024
Cardio Diagnostics Holdings
0.99%
▼ 28.98%
1
Open
Mar 08, 2024
Infobird Co
0.99%
▼ 65.43%
1
Open
Mar 08, 2024
Ocean Biomedical
0.99%
▼ 88.06%
1
Open
Mar 08, 2024
Akebia Therapeutics
0.99%
▲ 24.49%
1
Open
Mar 08, 2024
Agenus
0.99%
▼ 78.88%
1
Open
Mar 08, 2024
Legend Biotech
0.99%
▼ 46.12%
1
Open
Mar 08, 2024
Theratechnologies
0.99%
▲ 47.93%
1
Open
Mar 08, 2024
BeiGene
0.99%
▲ 11.34%
1
Open
Mar 08, 2024
Optinose
0.99%
▼ 75.00%
1
Open
Mar 08, 2024
Supernus Pharmaceuticals
0.99%
▲ 14.03%
1
Open
Mar 08, 2024
Cardiff Oncology
0.99%
▲ 2.90%
1
Open
Mar 08, 2024
Vanda
0.99%
▲ 23.51%
1
Open
Mar 08, 2024
Geron
0.99%
▲ 55.11%
1
Open
Mar 08, 2024
Liquidia Technologies
0.99%
▼ 20.94%
1
Open
Mar 08, 2024